Another Down Month for GWDN Index; Clinical Data Drops 24 Percent in June | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Only nine of the 34 stocks that comprise the GenomeWeb Daily News Index gained ground during another tough month for the stock market.

Three of the companies included in the Index — Clinical Data, Compugen, and Nanosphere — were hit hardest, with all of them falling more than 20 percent for June. Clinical Data had the largest decline, closing the month down 24 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.